Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SOLIGENIX, INC. Director's Dealing 2017

Jun 12, 2017

35119_dirs_2017-06-12_37cae5ad-8a6b-4ec9-a2a4-44d8ff74cf23.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SOLIGENIX, INC. (SNGX)
CIK: 0000812796
Period of Report: 2017-06-08

Reporting Person: ZELDIS JEROME B (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-06-08 Stock Option (Right to Buy) $2.29 A 13100 Acquired 2027-06-07 Common Stock (13100) Direct

Footnotes

F1: The stock option vests ratably on each of September 8, 2017, December 8, 2017, March 8, 2018 and June 8, 2018.